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Does psychiatric treatment help patients
with intractable chronic pain?
■ Evidence summary
Amitriptyline and other tricyclic and tetra-
cyclic antidepressants moderately improve
pain control for patients with chronic back
pain.1,2 The pain reduction was independent
of the presence of depression, although
patients who were depressed had a signifi-
cant improvement in mood. The outcome
on chronic pain of antidepressants with
serotonin and norepinephrine reuptake
inhibitory activity is still being evaluated. It
appears that those with only SSRI activity
are not effective improving chronic pain.2
Tricyclics are effective for diabetic neu-
ropathy (number needed to treat [NNT]=
3.5 for 50% reduction of pain),3 and they
are effective for reducing pain but not for
global symptoms in irritable bowel syn-
drome.4 Amitriptyline reduces the pain of
diabetic peripheral neuropathy in a dose-
Tricyclic antidepressants and intensive multi-
disciplinary programs are moderately effective 
for reducing chronic back pain; tricyclics are also
effective for diabetic neuropathy and irritable
bowel syndrome (strength of recommendation
[SOR]: A, meta-analyses and multiple small 
randomized controlled trials). 
Cognitive therapies are modestly effective for
reducing pain in the following: chronic back pain,
other chronic musculoskeletal disorders including
rheumatoid arthritis (SOR: B, multiple meta-
analyses with significant heterogeneity), and for
chronic cancer pain (SOR: B, 1 meta-analysis of
various quality studies).
E V I D E N C E - B A S E D A N S W E R
Consider tricyclics for all chronic pain sufferers
without a contraindication
Dealing with issues of chronic pain is frustrating
for both clinicians and patients. With inability to
relieve the patient’s pain, confounding factors of
medication overuse, noncompliance, and second-
ary gain or malingering often cloud the clinical 
picture. Add to this the high rate of comorbid
depression, and it makes sense to use behavioral
services in treating patient’s pain. 
But does it really help? The evidence indicates
that behavioral treatment helps some, but it
depends who is doing the treating, and the intensi-
ty of the therapy. By far the easiest evidence to put
into practice is the use of tricyclic antidepressants,
which should probably be prescribed to all chronic
pain sufferers who do not have a medical contra-
indication, such as suicide risk or heart disease.
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related manner up to 150 mg/d, although
much lower doses are often effective and
cause fewer anticholinergic side-effects.
For chronic back pain, a Cochrane
review including 1964 patients found
strong evidence for pain reduction and
modest evidence for functional improve-
ment from intensive (>100 hours) multi-
disciplinary biopsychosocial rehabilitation.
Less intense and less comprehensive psy-
chophysical programs did not reduce pain
or improve function.5 It was unclear if the
intensive programs were generalizable.
Another review found that cognitive and
progressive relaxation therapy had a mod-
erate effect on short-term pain control vs
waiting-list controls for chronic back pain.
However, only a third of the studies were of
“high quality,” and the total number of
patients in the relaxation analysis was 39.6
A systematic review of 25 studies
(1672 patients) found significant effect
sizes for cognitive therapies in reducing
pain and other symptoms in chronic mus-
culoskeletal pain, including rheumatoid
arthritis, fibromyalgia, back, and other pain
syndromes.7 However, many of the trials
were small or taken from “samples of con-
venience” from rehabilitation and pain
clinics, and most lacked documentation of
randomization. For rheumatoid arthritis
alone, a systematic review of 19 studies
found cognitive therapies had a small but
statistically significant effect on pain, func-
tional disability, depression, coping, and
self-efficacy for 1298 patients at initial fol-
low-up. However, only “tender points”
and coping remained improved at subse-
quent follow-ups averaging 8.5 months.8
In adults with cancer pain, a recent
meta-analysis of 1723 patients showed
modest but significant effects on pain from
psycho-educational interventions in 25
studies.9 Although just 3 of the studies last-
ed 52 weeks or longer, effects were found
from good-quality studies for “relaxation-
promoting,” educational, and supportive
counseling plus content therapies.
A significant confounder in many of
these studies may be that some treatments
seem more effective in secondary care than
in primary care settings, as based on a sys-
temic review of interventions for somatic
symptoms in primary care.10
Recommendations from others
The NIH states that antidepressants are
effective adjuvants in pain management,
and that cognitive-behavioral treatments
may be beneficial.11 The American Society
of Anesthesiology states that “the literature
supports the use of antidepressants for
reducing chronic pain without notable
adverse effects.”12 The Arthritis Foundation
lists amitriptyline, duloxetine, fluoxetine,
and paroxetine as treatment options for
pain and for helping sleep in fibromyalgia.13
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While there is no
evidence treating
psychiatric illness
impacts chronic
pain, pain control
is improved by
some psychologic
agents and 
interventions
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